Oxurion to Participate in Needham Virtual Healthcare Conference
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Stay updated with breaking news from Tom Graney. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Investegate announcements from Oxurion NV, Oxurion Receives Transparency Notifications from Fidelity Management & Research Company LLC and Novartis Pharma AG
Leuven, Belgium, Boston, MA, US - March 17, 2022 - 07.00 PM CET - Oxurion NV(Euronext Brussels: OXUR) (the "Company" or "Oxurion"), a biopharmaceutical company developing next generation
Led by new top-tier healthcare institutional investors along with participation by current major shareholders Leuven, BELGIUM, Boston, MA, US - MARCH 7, 2022 - 10.00 AM CET - Oxurion
Investegate announcements from Oxurion NV, OXURION SUCCESSFULLY RAISES EUR